世界の全身麻酔（TIVA）市場2021-2026：プロポフォール、エトミデート、ミダゾラム、バルビツール酸塩、その他

◆英語タイトル：Global Total Intravenous Anesthesia (TIVA) Market Growth 2021-2026
◆商品コード：LPI21MY9675
◆発行会社（リサーチ会社）：LP Information
◆発行日：2021年5月（※2024年版があります。お問い合わせください）
◆ページ数：166
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥541,680	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥812,520	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,083,360	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「全身麻酔（TIVA）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、プロポフォール、エトミデート、ミダゾラム、バルビツール酸塩、その他など、用途別には、主緊急、整形外科、美容整形、その他などにセグメント区分してまとめました。全身麻酔（TIVA）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・全身麻酔（TIVA）の世界市場概要（サマリー）
・全身麻酔（TIVA）の企業別販売量・売上
・全身麻酔（TIVA）の企業別市場シェア
・全身麻酔（TIVA）の世界市場規模 2016年-2021年：種類別（プロポフォール、エトミデート、ミダゾラム、バルビツール酸塩、その他）
・全身麻酔（TIVA）の世界市場規模 2016年-2021年：用途別（主緊急、整形外科、美容整形、その他）
・全身麻酔（TIVA）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・全身麻酔（TIVA）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・全身麻酔（TIVA）のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・全身麻酔（TIVA）の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・全身麻酔（TIVA）市場の成長要因・課題・動向
・全身麻酔（TIVA）の世界市場予測 2021年-2026年
・全身麻酔（TIVA）の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・全身麻酔（TIVA）のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・全身麻酔（TIVA）のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・全身麻酔（TIVA）の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・全身麻酔（TIVA）の世界市場予測：種類別（プロポフォール、エトミデート、ミダゾラム、バルビツール酸塩、その他）
・全身麻酔（TIVA）の世界市場予測：用途別（主緊急、整形外科、美容整形、その他）
・主要企業分析

【レポートの概要】

According to this latest study, the 2021 growth of Total Intravenous Anesthesia (TIVA) will have significant change from previous year. By the most conservative estimates of global Total Intravenous Anesthesia (TIVA) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Total Intravenous Anesthesia (TIVA) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Total Intravenous Anesthesia (TIVA) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Propofol
Etomidate
Midazolam
Barbiturates
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Predominantly Emergency
Orthopedic
Cosmetic Surgeries
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
B. Braun Medical
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Total Intravenous Anesthesia (TIVA) Consumption 2016-2026
2.1.2 Total Intravenous Anesthesia (TIVA) Consumption CAGR by Region
2.2 Total Intravenous Anesthesia (TIVA) Segment by Type
2.2.1 Propofol
2.2.2 Etomidate
2.2.3 Midazolam
2.2.4 Barbiturates
2.2.5 Others
2.3 Total Intravenous Anesthesia (TIVA) Sales by Type
2.3.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021)
2.3.2 Global Total Intravenous Anesthesia (TIVA) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Total Intravenous Anesthesia (TIVA) Sale Price by Type (2016-2021)
2.4 Total Intravenous Anesthesia (TIVA) Segment by Application
2.4.1 Predominantly Emergency
2.4.2 Orthopedic
2.4.3 Cosmetic Surgeries
2.4.4 Others
2.5 Total Intravenous Anesthesia (TIVA) Sales by Application
2.5.1 Global Total Intravenous Anesthesia (TIVA) Sale Market Share by Application (2016-2021)
2.5.2 Global Total Intravenous Anesthesia (TIVA) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Total Intravenous Anesthesia (TIVA) Sale Price by Application (2016-2021)

3 Global Total Intravenous Anesthesia (TIVA) by Company
3.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Company
3.1.1 Global Total Intravenous Anesthesia (TIVA) Sales by Company (2019-2021)
3.1.2 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Company (2019-2021)
3.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Company
3.2.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Company (2019-2021)
3.2.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Company (2019-2021)
3.3 Global Total Intravenous Anesthesia (TIVA) Sale Price by Company
3.4 Global Manufacturers Total Intravenous Anesthesia (TIVA) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Total Intravenous Anesthesia (TIVA) Product Location Distribution
3.4.2 Players Total Intravenous Anesthesia (TIVA) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Total Intravenous Anesthesia (TIVA) by Region
4.1 Global Total Intravenous Anesthesia (TIVA) by Region
4.1.1 Global Total Intravenous Anesthesia (TIVA) Sales by Region
4.1.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Region
4.2 Americas Total Intravenous Anesthesia (TIVA) Sales Growth
4.3 APAC Total Intravenous Anesthesia (TIVA) Sales Growth
4.4 Europe Total Intravenous Anesthesia (TIVA) Sales Growth
4.5 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Growth

5 Americas
5.1 Americas Total Intravenous Anesthesia (TIVA) Sales by Country
5.1.1 Americas Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021)
5.1.2 Americas Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021)
5.2 Americas Total Intravenous Anesthesia (TIVA) Sales by Type
5.3 Americas Total Intravenous Anesthesia (TIVA) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Total Intravenous Anesthesia (TIVA) Sales by Region
6.1.1 APAC Total Intravenous Anesthesia (TIVA) Sales by Region (2016-2021)
6.1.2 APAC Total Intravenous Anesthesia (TIVA) Revenue by Region (2016-2021)
6.2 APAC Total Intravenous Anesthesia (TIVA) Sales by Type
6.3 APAC Total Intravenous Anesthesia (TIVA) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Total Intravenous Anesthesia (TIVA) by Country
7.1.1 Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021)
7.1.2 Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021)
7.2 Europe Total Intravenous Anesthesia (TIVA) Sales by Type
7.3 Europe Total Intravenous Anesthesia (TIVA) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Total Intravenous Anesthesia (TIVA) by Country
8.1.1 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021)
8.2 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Type
8.3 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Total Intravenous Anesthesia (TIVA) Distributors
10.3 Total Intravenous Anesthesia (TIVA) Customer

11 Global Total Intravenous Anesthesia (TIVA) Market Forecast
11.1 Global Total Intravenous Anesthesia (TIVA) Forecast by Region
11.1.1 Global Total Intravenous Anesthesia (TIVA) Forecast by Regions (2021-2026)
11.2.2 Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Total Intravenous Anesthesia (TIVA) Forecast by Type
11.7 Global Total Intravenous Anesthesia (TIVA) Forecast by Application

12 Key Players Analysis
12.1 B. Braun Medical
12.1.1 B. Braun Medical Company Information
12.1.2 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Offered
12.1.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 B. Braun Medical Main Business Overview
12.1.5 B. Braun Medical Latest Developments
12.2 Astrazeneca
12.2.1 Astrazeneca Company Information
12.2.2 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Offered
12.2.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Astrazeneca Main Business Overview
12.2.5 Astrazeneca Latest Developments
12.3 Fresenius-Kabi
12.3.1 Fresenius-Kabi Company Information
12.3.2 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Offered
12.3.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Fresenius-Kabi Main Business Overview
12.3.5 Fresenius-Kabi Latest Developments
12.4 AbbVie
12.4.1 AbbVie Company Information
12.4.2 AbbVie Total Intravenous Anesthesia (TIVA) Product Offered
12.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 AbbVie Main Business Overview
12.4.5 AbbVie Latest Developments
12.5 Baxter Healthcare
12.5.1 Baxter Healthcare Company Information
12.5.2 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Offered
12.5.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Baxter Healthcare Main Business Overview
12.5.5 Baxter Healthcare Latest Developments
12.6 Maruishi
12.6.1 Maruishi Company Information
12.6.2 Maruishi Total Intravenous Anesthesia (TIVA) Product Offered
12.6.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Maruishi Main Business Overview
12.6.5 Maruishi Latest Developments
12.7 Piramal
12.7.1 Piramal Company Information
12.7.2 Piramal Total Intravenous Anesthesia (TIVA) Product Offered
12.7.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Piramal Main Business Overview
12.7.5 Piramal Latest Developments
12.8 Hikma Pharmaceuticals
12.8.1 Hikma Pharmaceuticals Company Information
12.8.2 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Offered
12.8.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Hikma Pharmaceuticals Main Business Overview
12.8.5 Hikma Pharmaceuticals Latest Developments
12.9 Mylan
12.9.1 Mylan Company Information
12.9.2 Mylan Total Intravenous Anesthesia (TIVA) Product Offered
12.9.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Mylan Main Business Overview
12.9.5 Mylan Latest Developments
12.10 Nhwa
12.10.1 Nhwa Company Information
12.10.2 Nhwa Total Intravenous Anesthesia (TIVA) Product Offered
12.10.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Nhwa Main Business Overview
12.10.5 Nhwa Latest Developments
12.11 Hengrui
12.11.1 Hengrui Company Information
12.11.2 Hengrui Total Intravenous Anesthesia (TIVA) Product Offered
12.11.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Hengrui Main Business Overview
12.11.5 Hengrui Latest Developments
12.12 Lunan
12.12.1 Lunan Company Information
12.12.2 Lunan Total Intravenous Anesthesia (TIVA) Product Offered
12.12.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Lunan Main Business Overview
12.12.5 Lunan Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Total Intravenous Anesthesia (TIVA) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Propofol
Table 3. Major Players of Etomidate
Table 4. Major Players of Midazolam
Table 5. Major Players of Barbiturates
Table 6. Major Players of Others
Table 7. Global Total Intravenous Anesthesia (TIVA) Sales by Type (2016-2021) & (K Units)
Table 8. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021)
Table 9. Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2016-2021) & ($ million)
Table 10. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2016-2021)
Table 11. Global Total Intravenous Anesthesia (TIVA) Sale Price by Type (2016-2021)
Table 12. Global Total Intravenous Anesthesia (TIVA) Sales by Application (2016-2021) & (K Units)
Table 13. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021)
Table 14. Global Total Intravenous Anesthesia (TIVA) Value by Application (2016-2021)
Table 15. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2016-2021)
Table 16. Global Total Intravenous Anesthesia (TIVA) Sale Price by Application (2016-2021)
Table 17. Global Total Intravenous Anesthesia (TIVA) Sales by Company (2019-2021) & (K Units)
Table 18. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Company (2019-2021)
Table 19. Global Total Intravenous Anesthesia (TIVA) Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Company (2019-2021)
Table 21. Global Total Intravenous Anesthesia (TIVA) Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Total Intravenous Anesthesia (TIVA) Producing Area Distribution and Sales Area
Table 23. Players Total Intravenous Anesthesia (TIVA) Products Offered
Table 24. Total Intravenous Anesthesia (TIVA) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2016-2021) (K Units)
Table 28. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2016-2021)
Table 29. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2016-2021)
Table 31. Americas Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021) & (K Units)
Table 32. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2016-2021)
Table 33. Americas Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2016-2021)
Table 35. Americas Total Intravenous Anesthesia (TIVA) Sales by Type (2016-2021) & (K Units)
Table 36. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021)
Table 37. Americas Total Intravenous Anesthesia (TIVA) Sales by Application (2016-2021) & (K Units)
Table 38. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021)
Table 39. APAC Total Intravenous Anesthesia (TIVA) Sales by Region (2016-2021) & (K Units)
Table 40. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2016-2021)
Table 41. APAC Total Intravenous Anesthesia (TIVA) Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2016-2021)
Table 43. APAC Total Intravenous Anesthesia (TIVA) Sales by Type (2016-2021) & (K Units)
Table 44. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021)
Table 45. APAC Total Intravenous Anesthesia (TIVA) Sales by Application (2016-2021) & (K Units)
Table 46. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021)
Table 47. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021) & (K Units)
Table 48. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2016-2021)
Table 49. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2016-2021)
Table 51. Europe Total Intravenous Anesthesia (TIVA) Sales by Type (2016-2021) & (K Units)
Table 52. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021)
Table 53. Europe Total Intravenous Anesthesia (TIVA) Sales by Application (2016-2021) & (K Units)
Table 54. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Total Intravenous Anesthesia (TIVA)
Table 64. Key Application and Potential Industries of Total Intravenous Anesthesia (TIVA)
Table 65. Key Challenges of Total Intravenous Anesthesia (TIVA)
Table 66. Key Trends of Total Intravenous Anesthesia (TIVA)
Table 67. Total Intravenous Anesthesia (TIVA) Distributors List
Table 68. Total Intravenous Anesthesia (TIVA) Customer List
Table 69. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Region (2021-2026) & (K Units)
Table 70. Global Total Intravenous Anesthesia (TIVA) Consumption Market Forecast by Region
Table 71. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Total Intravenous Anesthesia (TIVA) Sales Forecast by Country (2021-2026) & (K Units)
Table 74. Americas Total Intravenous Anesthesia (TIVA) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Total Intravenous Anesthesia (TIVA) Sales Forecast by Region (2021-2026) & (K Units)
Table 76. APAC Total Intravenous Anesthesia (TIVA) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Total Intravenous Anesthesia (TIVA) Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Europe Total Intravenous Anesthesia (TIVA) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Forecast by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Type (2021-2026) & (K Units)
Table 82. Global Total Intravenous Anesthesia (TIVA) Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Application (2021-2026) & (K Units)
Table 86. Global Total Intravenous Anesthesia (TIVA) Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Application (2021-2026)
Table 89. B. Braun Medical Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 90. B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Offered
Table 91. B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 92. B. Braun Medical Main Business
Table 93. B. Braun Medical Latest Developments
Table 94. Astrazeneca Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 95. Astrazeneca Total Intravenous Anesthesia (TIVA) Product Offered
Table 96. Astrazeneca Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. Astrazeneca Main Business
Table 98. Astrazeneca Latest Developments
Table 99. Fresenius-Kabi Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 100. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Offered
Table 101. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. Fresenius-Kabi Main Business
Table 103. Fresenius-Kabi Latest Developments
Table 104. AbbVie Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 105. AbbVie Total Intravenous Anesthesia (TIVA) Product Offered
Table 106. AbbVie Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. AbbVie Main Business
Table 108. AbbVie Latest Developments
Table 109. Baxter Healthcare Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 110. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Offered
Table 111. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. Baxter Healthcare Main Business
Table 113. Baxter Healthcare Latest Developments
Table 114. Maruishi Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 115. Maruishi Total Intravenous Anesthesia (TIVA) Product Offered
Table 116. Maruishi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Maruishi Main Business
Table 118. Maruishi Latest Developments
Table 119. Piramal Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 120. Piramal Total Intravenous Anesthesia (TIVA) Product Offered
Table 121. Piramal Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 122. Piramal Main Business
Table 123. Piramal Latest Developments
Table 124. Hikma Pharmaceuticals Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 125. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Offered
Table 126. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 127. Hikma Pharmaceuticals Main Business
Table 128. Hikma Pharmaceuticals Latest Developments
Table 129. Mylan Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 130. Mylan Total Intravenous Anesthesia (TIVA) Product Offered
Table 131. Mylan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 132. Mylan Main Business
Table 133. Mylan Latest Developments
Table 134. Nhwa Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 135. Nhwa Total Intravenous Anesthesia (TIVA) Product Offered
Table 136. Nhwa Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 137. Nhwa Main Business
Table 138. Nhwa Latest Developments
Table 139. Hengrui Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 140. Hengrui Total Intravenous Anesthesia (TIVA) Product Offered
Table 141. Hengrui Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 142. Hengrui Main Business
Table 143. Hengrui Latest Developments
Table 144. Lunan Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 145. Lunan Total Intravenous Anesthesia (TIVA) Product Offered
Table 146. Lunan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 147. Lunan Main Business
Table 148. Lunan Latest Developments
List of Figures
Figure 1. Picture of Total Intravenous Anesthesia (TIVA)
Figure 2. Total Intravenous Anesthesia (TIVA) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Total Intravenous Anesthesia (TIVA) Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Total Intravenous Anesthesia (TIVA) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Total Intravenous Anesthesia (TIVA) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Propofol
Figure 10. Product Picture of Etomidate
Figure 11. Product Picture of Midazolam
Figure 12. Product Picture of Barbiturates
Figure 13. Product Picture of Others
Figure 14. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type in 2020
Figure 15. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2016-2021)
Figure 16. Total Intravenous Anesthesia (TIVA) Consumed in Predominantly Emergency
Figure 17. Global Total Intravenous Anesthesia (TIVA) Market: Predominantly Emergency (2016-2021) & (K Units)
Figure 18. Total Intravenous Anesthesia (TIVA) Consumed in Orthopedic
Figure 19. Global Total Intravenous Anesthesia (TIVA) Market: Orthopedic (2016-2021) & (K Units)
Figure 20. Total Intravenous Anesthesia (TIVA) Consumed in Cosmetic Surgeries
Figure 21. Global Total Intravenous Anesthesia (TIVA) Market: Cosmetic Surgeries (2016-2021) & (K Units)
Figure 22. Total Intravenous Anesthesia (TIVA) Consumed in Others
Figure 23. Global Total Intravenous Anesthesia (TIVA) Market: Others (2016-2021) & (K Units)
Figure 24. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021)
Figure 25. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application in 2020
Figure 26. Total Intravenous Anesthesia (TIVA) Revenue Market by Company in 2020 ($ Million)
Figure 27. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Company in 2020
Figure 28. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Regions (2016-2021)
Figure 29. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region in 2020
Figure 30. Americas Total Intravenous Anesthesia (TIVA) Sales 2016-2021 (K Units)
Figure 31. Americas Total Intravenous Anesthesia (TIVA) Revenue 2016-2021 ($ Millions)
Figure 32. APAC Total Intravenous Anesthesia (TIVA) Sales 2016-2021 (K Units)
Figure 33. APAC Total Intravenous Anesthesia (TIVA) Revenue 2016-2021 ($ Millions)
Figure 34. Europe Total Intravenous Anesthesia (TIVA) Sales 2016-2021 (K Units)
Figure 35. Europe Total Intravenous Anesthesia (TIVA) Revenue 2016-2021 ($ Millions)
Figure 36. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales 2016-2021 (K Units)
Figure 37. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue 2016-2021 ($ Millions)
Figure 38. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Country in 2020
Figure 39. Americas Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country in 2020
Figure 40. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Type in 2020
Figure 41. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Application in 2020
Figure 42. United States Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 43. Canada Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 44. Mexico Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 45. Brazil Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 46. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Region in 2020
Figure 47. APAC Total Intravenous Anesthesia (TIVA) Revenue Market Share by Regions in 2020
Figure 48. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Type in 2020
Figure 49. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Application in 2020
Figure 50. China Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 51. Japan Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 52. Korea Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 53. Southeast Asia Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 54. India Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 55. Australia Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 56. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Country in 2020
Figure 57. Europe Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country in 2020
Figure 58. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Type in 2020
Figure 59. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Application in 2020
Figure 60. Germany Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 61. France Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 62. UK Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 63. Italy Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 64. Russia Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 65. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Country in 2020
Figure 66. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country in 2020
Figure 67. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Type in 2020
Figure 68. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Application in 2020
Figure 69. Egypt Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 70. South Africa Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 71. Israel Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 72. Turkey Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 73. GCC Country Total Intravenous Anesthesia (TIVA) Revenue Growth 2016-2021 ($ Millions)
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の全身麻酔（TIVA）市場2021-2026：プロポフォール、エトミデート、ミダゾラム、バルビツール酸塩、その他(Global Total Intravenous Anesthesia (TIVA) Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp